Pivotal Phase 3 VERITAC-2 clinical trial results presented at ASCO demonstrate 2.9-month improvement in median progression-free survival when compared to fulvestrant in second line-plus patients with ...

Metabolic dysfunction–associated steatohepatitis (MASH) is the new term for non-alcoholic steatohepatitis (NASH). There are ...

Agricultural scientists from the National Livestock Resources Research Institute (NaLIRRI) have been conducting intensive research since 2016 to develop an anti-tick vaccine aimed at ...

Summit Therapeutics Inc.'s faces FDA hurdles as its HARMONi study shows mixed results on ivonescimab. Click here to find out ...

The global Biomarkers Market, valued at US$58.07 billion in 2024 stood at US$62.39 billion in 2025 and is projected to advance at a resilient CAGR of 10.8% from 2025 to 2030, culminating in a ...

Japanese drugmaker Sumitomo Pharma (TYO: 4506) and Denmark’s Novo Nordisk (NOV: N) have entered into a co-promotion agreement ...

According to our analysis of U.S. Census Bureau data, the Detroit-Warren-Dearborn metro area grew by 1.2%, from a total population of 4,291,843 in 2010 to 4,342,304 in 2023.

The field of gynecological oncology has been significantly transformed by the advancements in molecular biology and precision medicine. These innovations ...

Colorectal surgery is undergoing a revolution with the integration of artificial intelligence (AI), robotic systems, and precision medicine. These ...

A typical advertisement for a prescription drug airs on television. The visuals are lively and upbeat; the people are smiling ...

BioVaxys Technology Corp. (CSE: BIOV) (FRA: 5LB) ("BioVaxys" or the "Company") announces a proposed consolidation of the ...

NEW YORK, May 30, 2025 (GLOBE NEWSWIRE) -- TG Therapeutics, Inc. (NASDAQ: TGTX), today announced the presentations of data highlighting BRIUMVI® (ublituximab-xiiy) in patients with relapsing forms of ...